Abstract

In Reply. —We agree with Drs Clarfield, Friedman, and Bergman that hypertension is an important risk factor in the elderly; in fact, some of our previous work is on this topic. 1 However, the present study focused on middle-aged men because the goal was to examine findings in the Multiple Risk Factor Intervention Trial (MRFIT), which found an association between diuretic therapy (especially hydrochlorothiazide) and an increased rate of sudden death in hypertensive men 35 to 57 years of age with electrocardiographic abnormalities. 2 In our study, we extended the age range to 35 to 70 years. It is of interest that the Systolic Hypertension in the Elderly Program study cited by Clarfield and colleagues restricted enrollment to individuals 60 years and above. There may be research questions [ill] most appropriate for particular age groups. In general, we agree with the thrust of Dr Papademetriou's work, which indicates that hydrochlorothiazide

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.